Role of Lung Ultrasound and Pulsed-wave Doppler in Lung Consolidations in Mechanically Ventilated Patients

Sponsor
Centre hospitalier de l'Université de Montréal (CHUM) (Other)
Overall Status
Recruiting
CT.gov ID
NCT02100449
Collaborator
Centre de Recherche du Centre Hospitalier de l'Université de Montréal (Other)
64
1
2
101
0.6

Study Details

Study Description

Brief Summary

In infectious lung consolidations, the inhibition of hypoxic pulmonary vasoconstriction (HPV) results in a higher regional acceleration time (RAcT) compared to the RAcT measured in atelectatic consolidations.

Condition or Disease Intervention/Treatment Phase
  • Other: Lung ultrasound and Doppler (Day 0)
  • Other: Lung ultrasound and Doppler (Day 0 and Day 3 to 5)
N/A

Detailed Description

Ventilator-associated pneumonia has a considerable impact on morbidity and mortality in intensive-care patients. Chest radiography, which is the most frequently used imagery test for bedside lung evaluation in mechanically ventilated patients, is recognized to be poorly sensitive and non-specific for the diagnosis of ventilator-associated pneumonia. Bronchoalveolar lavage using a bronchoscope remains the most reliable tool for the diagnosis of this nosocomial infection. However, a bronchoscopy may not be feasible in all patients and waiting time before final results become available may cause a delay in the initiation of the treatment, thus increasing the risk of mortality. Lung ultrasound is a promising non-invasive, non-radiant, portable and easy to use tool especially in critically-ill patients.

Dependent atelectasis is a frequent phenomenon in mechanically ventilated patients. The presence of clinical infection signs raises the question of the nature of the infiltrate. A consolidation of infectious nature differs from atelectasis by its local hypoxic pulmonary vasoconstriction inhibition. In patients breathing spontaneously, it is possible to detect this difference using the RAcT, measured by pulsed-wave Doppler in an arterial blood vessel located in a pulmonary consolidation visible by ultrasound examination. The use of pulsed-wave Doppler to measure the RAcT in a consolidation added to the value of general lung ultrasound could help determine the infectious or atelectatic nature of a consolidation in mechanically ventilated patients. However, the RAcT has never been studied in patients under positive pressure ventilation. In this observational study, the investigators will explore the role of measuring the RAcT and of general lung ultrasound as a diagnostic tool to detect pneumonia in mechanically ventilated patients.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
64 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Role of Lung Ultrasound Imaging and Pulsed-wave Doppler in the Assessment of Lung Consolidations in Mechanically Ventilated Patients.
Actual Study Start Date :
Jun 1, 2014
Anticipated Primary Completion Date :
Nov 1, 2022
Anticipated Study Completion Date :
Nov 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Other: Lung ultrasound and Doppler, pneumonia

In this group, a lung ultrasound examination using pulsed-wave Doppler will be performed in patients with high clinical suspicion of pneumonia on Day 0 and on Day 3 to 5. A bronchoalveolar lavage will also be performed on Day 0.

Other: Lung ultrasound and Doppler (Day 0 and Day 3 to 5)
In patients presenting a consolidation of suspected infectious nature, a lung ultrasound examination using pulsed-wave Doppler will be performed on Day 0 and on Day 3 to 5. A bronchoalveolar lavage will also be performed on Day 0.

Other: Lung ultrasound and Doppler, atelectasis

Patients without clinically active pulmonary disease but presenting a consolidation of suspected atelectatic nature. Fever, hypothermia, leucocytosis and leucopenia will not be present. Tracheal secretions will remain unchanged. There will be no deterioration of oxygenation. In this group, a lung ultrasound examination using pulsed-wave Doppler will be performed on Day 0 only.

Other: Lung ultrasound and Doppler (Day 0)
In patients presenting a consolidation of suspected atelectatic nature, a lung ultrasound examination using pulsed-wave Doppler will be performed on Day 0 only.

Outcome Measures

Primary Outcome Measures

  1. RAcT in lung consolidations [During lung ultrasound examination - Day 0]

    Regional acceleration time measured by lung ultrasound and pulsed-wave Doppler

Secondary Outcome Measures

  1. Temporal evolution of the RAcT [During lung ultrasound examination - On day 0 and on day 3 to 5 (for patients in the pneumonia group only)]

    Change in the RAcT between day 0 and day 3 to 5 lung ultrasound exams

  2. Presence of visible blood vessels on colour Doppler in lung consolidations [During lung ultrasound examination - Day 0]

    Graded semi-quantitatively (absence, single, multiple branching)

  3. Presence of dynamic air bronchograms in lung consolidations [During lung ultrasound examination - Day 0]

    To-and-fro respiratory movement of punctiform or linear hyperechoic artifacts (absence or presence)

  4. Presence of sub-pleural consolidations [During lung ultrasound examination - Day 0]

    Subpleural hypoechoic area with ragged margins (absence or presence)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Under mechanical ventilation and presenting one or more consolidations on chest radiography or CT scan
Exclusion Criteria:
  • Participation to another study

  • Poor echogenicity (morbid obesity, multiple thoracic dressings)

  • Contra-indications to superior limbs or torso mobilization

  • Contra-indications to bronchoscopy

  • Known pulmonary artery hypertension

  • Known right ventricular failure

  • Antibiotics initiated more than 12 hours but less than 72 hours before inclusion or changes in the antibiotic regimen in the last 72 hours.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Hospitalier de l'Université de Montréal (CHUM) Montreal Quebec Canada H2X 3E4

Sponsors and Collaborators

  • Centre hospitalier de l'Université de Montréal (CHUM)
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal

Investigators

  • Principal Investigator: Martin Girard, MD, FRCPC, Centre hospitalier de l'Université de Montréal (CHUM)

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre hospitalier de l'Université de Montréal (CHUM)
ClinicalTrials.gov Identifier:
NCT02100449
Other Study ID Numbers:
  • 14.005
First Posted:
Apr 1, 2014
Last Update Posted:
Jul 27, 2022
Last Verified:
Mar 1, 2022
Keywords provided by Centre hospitalier de l'Université de Montréal (CHUM)
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 27, 2022